全文获取类型
收费全文 | 43753篇 |
免费 | 2847篇 |
国内免费 | 251篇 |
专业分类
耳鼻咽喉 | 376篇 |
儿科学 | 1275篇 |
妇产科学 | 1199篇 |
基础医学 | 5789篇 |
口腔科学 | 928篇 |
临床医学 | 4408篇 |
内科学 | 9515篇 |
皮肤病学 | 877篇 |
神经病学 | 4713篇 |
特种医学 | 1481篇 |
外科学 | 5850篇 |
综合类 | 172篇 |
一般理论 | 19篇 |
预防医学 | 3154篇 |
眼科学 | 760篇 |
药学 | 2734篇 |
1篇 | |
中国医学 | 84篇 |
肿瘤学 | 3516篇 |
出版年
2024年 | 10篇 |
2023年 | 472篇 |
2022年 | 387篇 |
2021年 | 1617篇 |
2020年 | 1056篇 |
2019年 | 1484篇 |
2018年 | 1698篇 |
2017年 | 1189篇 |
2016年 | 1339篇 |
2015年 | 1542篇 |
2014年 | 2122篇 |
2013年 | 2642篇 |
2012年 | 3915篇 |
2011年 | 3903篇 |
2010年 | 1972篇 |
2009年 | 1841篇 |
2008年 | 3115篇 |
2007年 | 3002篇 |
2006年 | 2703篇 |
2005年 | 2674篇 |
2004年 | 2231篇 |
2003年 | 1995篇 |
2002年 | 1759篇 |
2001年 | 210篇 |
2000年 | 148篇 |
1999年 | 198篇 |
1998年 | 254篇 |
1997年 | 181篇 |
1996年 | 143篇 |
1995年 | 174篇 |
1994年 | 153篇 |
1993年 | 121篇 |
1992年 | 82篇 |
1991年 | 74篇 |
1990年 | 60篇 |
1989年 | 40篇 |
1988年 | 38篇 |
1987年 | 34篇 |
1986年 | 31篇 |
1985年 | 31篇 |
1984年 | 38篇 |
1983年 | 18篇 |
1982年 | 37篇 |
1981年 | 21篇 |
1980年 | 21篇 |
1979年 | 9篇 |
1978年 | 12篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1972年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
93.
94.
Louise A. Rollins-Smith J. Scott Fites Laura K. Reinert Andrea R. Shiakolas Thomas P. Umile Kevin P. C. Minbiole 《Infection and immunity》2015,83(12):4565-4570
Batrachochytrium dendrobatidis is a fungal pathogen in the phylum Chytridiomycota that causes the skin disease chytridiomycosis. Chytridiomycosis is considered an emerging infectious disease linked to worldwide amphibian declines and extinctions. Although amphibians have well-developed immune defenses, clearance of this pathogen from the skin is often impaired. Previously, we showed that the adaptive immune system is involved in the control of the pathogen, but B. dendrobatidis releases factors that inhibit in vitro and in vivo lymphocyte responses and induce lymphocyte apoptosis. Little is known about the nature of the inhibitory factors released by this fungus. Here, we describe the isolation and characterization of three fungal metabolites produced by B. dendrobatidis but not by the closely related nonpathogenic chytrid Homolaphlyctis polyrhiza. These metabolites are methylthioadenosine (MTA), tryptophan, and an oxidized product of tryptophan, kynurenine (Kyn). Independently, both MTA and Kyn inhibit the survival and proliferation of amphibian lymphocytes and the Jurkat human T cell leukemia cell line. However, working together, they become effective at much lower concentrations. We hypothesize that B. dendrobatidis can adapt its metabolism to release products that alter the local environment in the skin to inhibit immunity and enhance the survival of the pathogen. 相似文献
95.
Shi-Qiong Xu Simone Buraschi Alaide Morcavallo Marco Genua Tomoaki Shirao Stephen C. Peiper Leonard G. Gomella Ruth Birbe Antonino Belfiore Renato V. Iozzo Andrea Morrione 《Oncotarget》2015,6(13):10825-10839
We recently established a critical role for the growth factor progranulin in bladder cancer insofar as progranulin promotes urothelial cancer cell motility and contributes, as an autocrine growth factor, to the transformed phenotype by modulating invasion and anchorage-independent growth. In addition, progranulin expression is upregulated in invasive bladder cancer tissues compared to normal controls. However, the molecular mechanisms of progranulin action in bladder cancer have not been fully elucidated. In this study, we searched for novel progranulin-interacting proteins using pull-down assays with recombinant progranulin and proteomics. We discovered that drebrin, an F-actin binding protein, bound progranulin in urothelial cancer cells. We characterized drebrin function in urothelial cancer cell lines and showed that drebrin is critical for progranulin-dependent activation of the Akt and MAPK pathways and modulates motility, invasion and anchorage-independent growth. In addition, drebrin regulates tumor formation in vivo and its expression is upregulated in bladder cancer tissues compared to normal tissue controls. Our data are translationally relevant as indicate that drebrin exerts an essential functional role in the regulation of progranulin action and may constitute a novel target for therapeutic intervention in bladder tumors. In addition, drebrin may serve as novel biomarker for bladder cancer. 相似文献
96.
97.
Michela Colombo Serena Galletti Silvia Garavelli Natalia Platonova Alessandro Paoli Andrea Basile Elisa Taiana Antonino Neri Raffaella Chiaramonte 《Oncotarget》2015,6(29):26826-26840
Despite recent therapeutic advances, multiple myeloma (MM) is still an incurable neoplasia due to intrinsic or acquired resistance to therapy. Myeloma cell localization in the bone marrow milieu allows direct interactions between tumor cells and non-tumor bone marrow cells which promote neoplastic cell growth, survival, bone disease, acquisition of drug resistance and consequent relapse. Twenty percent of MM patients are at high-risk of treatment failure as defined by tumor markers or presentation as plasma cell leukemia. Cumulative evidences indicate a key role of Notch signaling in multiple myeloma onset and progression. Unlike other Notch-related malignancies, where the majority of patients carry gain-of-function mutations in Notch pathway members, in MM cell Notch signaling is aberrantly activated due to an increased expression of Notch receptors and ligands; notably, this also results in the activation of Notch signaling in surrounding stromal cells which contributes to myeloma cell proliferation, survival and migration, as well as to bone disease and intrinsic and acquired pharmacological resistance. Here we review the last findings on the mechanisms and the effects of Notch signaling dysregulation in MM and provide a rationale for a therapeutic strategy aiming at inhibiting Notch signaling, along with a complete overview on the currently available Notch-directed approaches. 相似文献
98.
Michelle Z. Farland Patrick B. Barlow T. Levi Lancaster Andrea S. Franks 《American journal of pharmaceutical education》2015,79(2)
Objective. To assess the impact of awarding partial credit to team assessments on team performance and on quality of team interactions using an answer-until-correct method compared to traditional methods of grading (multiple-choice, full-credit).Methods. Subjects were students from 3 different offerings of an ambulatory care elective course, taught using team-based learning. The control group (full-credit) consisted of those enrolled in the course when traditional methods of assessment were used (2 course offerings). The intervention group consisted of those enrolled in the course when answer-until-correct method was used for team assessments (1 course offering). Study outcomes included student performance on individual and team readiness assurance tests (iRATs and tRATs), individual and team final examinations, and student assessment of quality of team interactions using the Team Performance Scale.Results. Eighty-four students enrolled in the courses were included in the analysis (full-credit, n=54; answer-until-correct, n=30). Students who used traditional methods of assessment performed better on iRATs (full-credit mean 88.7 (5.9), answer-until-correct mean 82.8 (10.7), p<0.001). Students who used answer-until-correct method of assessment performed better on the team final examination (full-credit mean 45.8 (1.5), answer-until-correct 47.8 (1.4), p<0.001). There was no significant difference in performance on tRATs and the individual final examination. Students who used the answer-until-correct method had higher quality of team interaction ratings (full-credit 97.1 (9.1), answer-until-correct 103.0 (7.8), p=0.004).Conclusion. Answer-until-correct assessment method compared to traditional, full-credit methods resulted in significantly lower scores for iRATs, similar scores on tRATs and individual final examinations, improved scores on team final examinations, and improved perceptions of the quality of team interactions. 相似文献
99.
Elisa Giani Andrea Enzo Scaramuzza Gian Vincenzo Zuccotti 《World journal of diabetes》2015,6(8):999-1004
Technologies for diabetes management, such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems, have improved remarkably over the last decades. These developments are impacting the capacity to achieve recommended hemoglobin A1c levels and assisting in preventing the development and progression of micro- and macro vascular complications. While improvements in metabolic control and decreases in risk of severe and moderate hypoglycemia have been described with use of these technologies, large epidemiological international studies show that many patients are still unable to meet their glycemic goals, even when these technologies are used. This editorial will review the impact of technology on glycemic control, hypoglycemia and quality of life in children and youth with type 1 diabetes. Technologies reviewed include CSII, CGM systems and sensor-augmented insulin pumps. In addition, the usefulness of advanced functions such as bolus profiles, bolus calculators and threshold-suspend features will be also discussed. Moreover, the current editorial will explore the challenges of using these technologies. Indeed, despite the evidence currently available of the potential benefits of using advanced technologies in diabetes management, many patients still report barriers to using them. Finally this article will highlight the importance of future studies tailored toward overcome these barriers to optimizing glycemic control and avoiding severe hypoglycemia. 相似文献
100.